Clinical Trials on Immune Development in China

Total 4184 results

Peking Union Medical College Hospital

Recruiting

National Registry of IgG4-RD in China

IgG4-Related Disease

China
Beijing Boren Hospital

Terminated

A Study of OVV-01 Injection in Combination With IBR900 Cell Injection in Patients With Advanced Malignant Tumors

Advanced Solid Tumor | Relapsed/Refractory Lymphoma

China
Peking University People's Hospital

Unknown

Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice

Breast Cancer | Drug Effect | Neoadjuvant Chemotherapy

China
Peking University People's Hospital

Unknown

Conditioned Pain Modulation in Chronic Neck Pain Patients

Neck Pain

China
Changhai Hospital

Completed

Soluble Triggering Receptor Expressed on Myeloid Cells in Severe Acute Pancreatitis (STREM-1)

Pancreatitis | Acute

China
Xiaoli Fan

Unknown

Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis

Hepatitis, Autoimmune

China
Xiaoli Fan

Withdrawn

Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis

Hepatitis, Autoimmune

China
Qilu Hospital of Shandong University

Recruiting

A Prospective Birth Cohort of Infants With Allergy and Neurodevelopmental Disorders in China

Neurodevelopmental Disorders | Child Allergy

China
Fujian Medical University

Unknown

CART-19 Cells For R/R B-ALL (CCFRRBA)

Relapsed/Refractory B-cell ALL

China
Zhi-Hong Liu, M.D.
Nanjing Medical University; Soochow University

Completed

Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)

Amyloidosis

China
Chinese University of Hong Kong

Completed

The Chinese University of Hong Kong Early Arthritis Study (ERA)

Rheumatoid Arthritis

China
Institute of Hematology & Blood Diseases Hospital...
Henan Cancer Hospital; Tianjin Medical University Second Hospital; The Second... and other collaborators

Recruiting

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

Immune Thrombocytopenia | Treatment

China
Institute of Hematology & Blood Diseases Hospital

Recruiting

A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia (2022-CM313-ITP)

Immune Thrombocytopenia | Treatment

China
Peking University People's Hospital
Beijing Friendship Hospital; Beijing Hospital; The First Affiliated Hospital... and other collaborators

Recruiting

The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Immune Thrombocytopenia | ITP

China
Zhang Lei

Recruiting

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

Thrombocytopenia | Splenectomy

China
Institute of Hematology & Blood Diseases Hospital

Recruiting

Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease

aGVHD

China
Ying Wang

Recruiting

CD7 CAR-T for Patients With r/r CD7+ Hematologic Malignancies

Hematological Malignancies

China
Liu Tian

Recruiting

Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Peking University People's Hospital

Recruiting

Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Suez Canal University

Recruiting

Bispectral Index (BIS) for Classification of Procalcitonin (PCT) Sepsis Grades in Critically Ill Patients With Sepsis (BIS6)

Sepsis, Severe

China
GlaxoSmithKline

Completed

Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects

Systemic Lupus Erythematosus

China
Peking University People's Hospital
Monash University

Completed

Low-dose IL-2( Interleukin-2) Treatment in SLE

Systemic Lupus Erythematosus

China
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Unknown

A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Biotech Pharmaceutical Co., Ltd.

Recruiting

Safety and Clinical Activity of Itolizumab in aGVHD

Acute Graft Versus Host Disease

China
Peking University People's Hospital

Recruiting

MTX and Steroid for III-IV aGVHD Treatment

Acute Graft Versus Host Disease

China
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical...

Completed

A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients

Seasonal Allergic Conjunctivitis

China
Second Affiliated Hospital, School of Medicine,...

Unknown

Perioperative Risk Factors of Outcomes for Cardiac Surgery: A Retrospective Study

Prognosis | Post-cardiac Surgery | Blood Transfusion Complication

China
Novartis
Alcon Research

Completed

Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis

Seasonal Allergic Conjunctivitis

China
Peking University People's Hospital

Completed

A Study of Zanubrutinib in Patients With ITP

Immune Thrombocytopenia | Bruton Tyrosine Kinase

China
The First Affiliated Hospital of Soochow University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Recruiting

Anti-BCMA CAR T-Cell Therapy for R/R ITP

ITP

China
Guangzhou Institute of Respiratory Disease
Firestone Institute for Respiratory Health

Completed

Comparison of Methacholine Bronchial Provocation With Wright and Devilbiss646 Nebulizers

Asthma

China
Shanghai Jiaolian Drug Research and Development...
Shanghai Pharmaceuticals Holding Co., Ltd

Not yet recruiting

A Clinical Study of B007 in the Treatment of Pemphigus.

Pemphigus

China
Jiangsu Simcere Pharmaceutical Co., Ltd.
Second Hospital of Shanxi Medical University

Completed

A Pilot Bioequivalence Study of Pomalidomide

Bioequivalence

China
Peking Union Medical College Hospital

Completed

Belimumab In Early Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic

China
Jiangxi University of Traditional Chinese Medicine
Nangang community healthcare center (Nanchang city, Jiangxi province, China) and other collaborators

Active, not recruiting

Heat-sensitive Moxibustion Self-administration in Patients in the Community With Primary Hypertension: Protocol for a Multi-center, Pragmatic, Non-randomized Trial

Primary Hypertension

China
Huazhong University of Science and Technology
National Natural Science Foundation of China

Completed

Tooth Mousse and Fluoride in Dentin Hypersensitivity Treatment

Dentin Hypersensitivity

China
Fujian Medical University Union Hospital
The Affiliated Hospital Of Guizhou Medical University; The Second Hospital... and other collaborators

Recruiting

Short-course High-dose Prednisone and Dexamethasone in Children With ITP

Immune Thrombocytopenia | Child, Only | Glucocorticoids

China
Ruijin Hospital

Recruiting

Effect of Telitacicept on Antibody Titers in Primary APS Patients

Antiphospholipid Syndrome (APS)

China
Amgen

Completed

A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants

Atopic Dermatitis

China
Peking University Third Hospital

Completed

The Hug-up Test: A New, Sensitive Diagnostic Test for Supraspinatus Tears

Rotator Cuff Tears

China
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Screening Biomarkers for Severe Lupus Based on Multi-omics Studies

Systemic Lupus Erythematosus

China
Yi Luo

Recruiting

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Leukemia | Graft-versus-host-disease

China
RenJi Hospital

Recruiting

Efficacy and Safety of Belimumab in SLE Patients

Systemic Lupus Erythematosus

China
Ruijin Hospital

Completed

Endocytoscopy of Upper Gastrointestinal Tract in Acute Graft-versus-host Disease: a Pilot Study

Endocytoscopy

China
RenJi Hospital
Jiangsu ZuoYou Medicine Co., Ltd.

Completed

Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Peking University People's Hospital

Completed

G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation

Stem Cell Transplantation | Graft Versus Host Disease | Poor Graft Function

China
Air Force Military Medical University, China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Completed

Association Between Mitochondrial DNA Content and Risk of Acute Leukemia

Lymphoblastic Leukemia in Children

China
Shanghai University of Traditional Chinese Medicine
RenJi Hospital

Unknown

The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China

Clinical Trials on Immune Development in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations